Rheumatology
331 – 340 of 1671
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod
- Contribution to journal › Article
-
Mark
Reported disability in relation to observed activity limitation, grip strength and physical function in women and men with rheumatoid arthritis
- Contribution to journal › Article
-
Mark
Anterior uveitis in patients with spondyloarthritis treated with secukinumab or tumour necrosis factor inhibitors in routine care : Does the choice of biological therapy matter?
- Contribution to journal › Article
-
Mark
Comment on: EPIDEMIOLOGY OF BIOPSY-CONFIRMED GIANT CELL ARTERITIS IN SOUTHERN SWEDEN-AN UPDATE ON INCIDENCE AND FIRST PREVALENCE ESTIMATE: Reply
- Contribution to journal › Article
-
Mark
Clinical and Epidemiological Studies on Giant Cell Arteritis
(2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
Variants in BANK1 are associated with lupus nephritis of European ancestry
- Contribution to journal › Article
-
Mark
Influence of age and sex on disease course and treatment in rheumatoid arthritis
- Contribution to journal › Article
-
Mark
Higher levels of anti-phosphorylcholine autoantibodies in early rheumatoid arthritis indicate lower risk of incident cardiovascular events
- Contribution to journal › Article
-
Mark
Disease activity trajectories in rheumatoid arthritis : a tool for prediction of outcome
- Contribution to journal › Article
-
Mark
Pain over 2 years after start of biological versus conventional combination treatment in early rheumatoid arthritis : results from the randomised controlled SWEFOT trial
- Contribution to journal › Article
